Skip to content

Ginkgo Bioworks DNA FX Effect on Cash

FX Effect on Cash at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$78M+111%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.25M-76.3%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$38K-106%
TEC
Bio-TechneTECH
-$1.19M-9.9%
Azenta logo
AzentaAZTA
-$2.44M
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$30K-58.9%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's FX effect on cash?
Ginkgo Bioworks (DNA) reported FX effect on cash of -$129K in Q1 2026.
How has Ginkgo Bioworks's FX effect on cash changed year-over-year?
Ginkgo Bioworks's FX effect on cash decreased by 274.3% year-over-year, from $74K to -$129K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.